Paul Schimmel

E524754

Paul Schimmel is an American biochemist and biotechnology entrepreneur known for his pioneering work on aminoacyl-tRNA synthetases and for co-founding multiple biotech companies.

All labels observed (1)

Label Occurrences
Paul Schimmel canonical 2

How this entity was disambiguated

Statements (47)

Predicate Object
instanceOf academic
biochemist
biotechnology entrepreneur
academicDegree Bachelor of Arts in chemistry
PhD in biophysical chemistry
coFounded Alkermes
Alnylam Pharmaceuticals
Cubist Pharmaceuticals
Repligen
Schrodinger, Inc.
Sirtris Pharmaceuticals
aTyr Pharma
countryOfCitizenship United States of America
educatedAt Massachusetts Institute of Technology
Ohio Wesleyan University
employer Massachusetts Institute of Technology
The Scripps Research Institute
fieldOfWork RNA biology
biochemistry
molecular biology
structural biology
hasPublishedOn disease associations of tRNA synthetases
editing functions in tRNA aminoacylation
structure–function relationships of aminoacyl-tRNA synthetases
hasReceivedAward American Chemical Society Pfizer Award in Enzyme Chemistry
American Chemical Society Ralph F. Hirschmann Award in Peptide Chemistry
Biophysical Society Founders Award
National Institutes of Health MERIT Award
hasWritten scientific articles on aminoacyl-tRNA synthetases
textbooks on biophysical chemistry
knownFor linking tRNA synthetase biology to human disease
translating basic RNA biology into therapeutics
languageOfWorkOrName English
memberOf American Academy of Arts and Sciences
American Philosophical Society
National Academy of Sciences of the United States of America
notableFor biotechnology company founding
pioneering work on the genetic code
research on aminoacyl-tRNA synthetases
occupation biochemist
biotechnology entrepreneur
professor
positionHeld Ernest and Jean Hahn Professor at The Scripps Research Institute
Professor of Biochemistry at MIT
researchFocus aminoacyl-tRNA synthetases
mechanisms of protein synthesis
noncanonical functions of tRNA synthetases

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Alnylam Pharmaceuticals foundedBy Paul Schimmel
Alnylam Pharmaceuticals, Inc. foundedBy Paul Schimmel
subject linked to: ALNY